                         SEQUENCE LISTING

<110>  ARIZONA CANCER THERAPEUTICS, LLC
       Schroeder, Joyce
 
<120>  EGFR-BASED INHIBITOR PEPTIDES FOR COMBINATORIAL INACTIVATION OF 
       ERBB1, ERBB2, AND ERBB3

<130>  ACT 16.04 PCT

<140>  PCT/US16/25905
<141>  2016-04-04

<150>  US 62/142,962
<151>  2015-04-03

<150>  US 62/213,039
<151>  2015-09-01

<150>  US 62/214,098
<151>  2015-09-03

<150>  US 15/090,316
<151>  2016-04-04

<160>  109   

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  1

Phe Met Arg Arg Arg His Ile Val Arg Lys Arg Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  2
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  2

Phe Arg Met His Arg Ile Arg Val Arg Thr Lys Leu Arg Leu Arg Leu 
1               5                   10                  15      


Arg Gln Glu Arg Glu 
            20      


<210>  3
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  3

Phe Met Arg Gln Arg His Ile Val Arg Gln Arg Thr Leu Arg Gln Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  4

Ile Val Arg Lys Arg Thr Leu Arg Arg Leu Leu Gln Glu Arg Glu 
1               5                   10                  15  


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  5

Ile Val Arg Thr Lys Leu Arg Leu Arg Leu Arg Gln Glu Arg Glu 
1               5                   10                  15  


<210>  6
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  6

Arg Thr Leu Arg Arg Leu Leu Gln Glu Arg Glu 
1               5                   10      


<210>  7
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  7

Phe Met Arg Arg Arg His Ile Val Arg Lys Arg Thr Leu 
1               5                   10              


<210>  8
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  8

Arg Arg Arg His Ile Val Arg Lys Arg Thr Leu Arg Arg 
1               5                   10              


<210>  9
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  9

Phe Arg Met His Arg Ile Arg Val Arg Thr Lys Leu Arg 
1               5                   10              


<210>  10
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  10

Leu Leu Gln Glu Arg Glu 
1               5       


<210>  11
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  11

Arg Asp Arg His Ile Val Arg Asp Arg Thr Leu Arg Asp 
1               5                   10              


<210>  12
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  12

Phe Met Arg Asp Arg His Ile Val Arg Asp Arg Thr Leu Arg Asp Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  13
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  13

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Phe Met Arg Arg Arg 
1               5                   10                  15      


His Ile Val Arg Lys Arg Thr Leu Arg Arg Leu Leu Gln Glu Arg Glu 
            20                  25                  30          


<210>  14
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  14

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Phe Arg Met His Arg 
1               5                   10                  15      


Ile Arg Val Arg Thr Lys Leu Arg Leu Arg Leu Arg Gln Glu Arg Glu 
            20                  25                  30          


<210>  15
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  15

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Phe Met Arg Gln Arg 
1               5                   10                  15      


His Ile Val Arg Gln Arg Thr Leu Arg Gln Leu Leu Gln Glu Arg Glu 
            20                  25                  30          


<210>  16
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  16

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Ile Val Arg Lys Arg 
1               5                   10                  15      


Thr Leu Arg Arg Leu Leu Gln Glu Arg Glu 
            20                  25      


<210>  17
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  17

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Ile Val Arg Thr Lys 
1               5                   10                  15      


Leu Arg Leu Arg Leu Arg Gln Glu Arg Glu 
            20                  25      


<210>  18
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  18

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Arg Thr Leu Arg Arg 
1               5                   10                  15      


Leu Leu Gln Glu Arg Glu 
            20          


<210>  19
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  19

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Phe Met Arg Arg Arg 
1               5                   10                  15      


His Ile Val Arg Lys Arg Thr Leu 
            20                  


<210>  20
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  20

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Arg Arg Arg His Ile 
1               5                   10                  15      


Val Arg Lys Arg Thr Leu Arg Arg 
            20                  


<210>  21
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  21

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Phe Arg Met His Arg 
1               5                   10                  15      


Ile Arg Val Arg Thr Lys Leu Arg 
            20                  


<210>  22
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  22

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Leu Leu Gln Glu Arg 
1               5                   10                  15      


Glu Leu Val Glu Pro Leu Thr 
            20              


<210>  23
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  23

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Arg Asp Arg His Ile 
1               5                   10                  15      


Val Arg Asp Arg Thr Leu Arg Asp 
            20                  


<210>  24
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  24

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Phe Met Arg Asp Arg 
1               5                   10                  15      


His Ile Val Arg Asp Arg Thr Leu Arg Asp Leu Leu Gln Glu Arg Glu 
            20                  25                  30          


<210>  25
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  25

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Ala Ala Gln Glu Arg 
1               5                   10                  15      


Glu Ala Ala Glu Pro Leu Thr 
            20              


<210>  26
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  26

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala Phe Met Ala Ala Ala 
1               5                   10                  15      


His Ile Val Ala Ala Ala Thr Leu Ala Ala Leu Leu Gln Glu Arg Glu 
            20                  25                  30          


<210>  27
<211>  40
<212>  PRT
<213>  Homo sapiens

<400>  27

Leu Leu Leu Val Val Ala Leu Gly Ile Gly Leu Phe Met Arg Arg Arg 
1               5                   10                  15      


His Ile Val Arg Lys Arg Thr Leu Arg Arg Leu Leu Gln Glu Arg Glu 
            20                  25                  30          


Leu Val Glu Pro Leu Thr Pro Ser 
        35                  40  


<210>  28
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  28

Phe Met Arg Arg Arg His Ile Leu Arg Gln Arg Thr Val Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  29
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  29

Phe Met Arg Arg His His Val Leu Arg Lys Arg Thr Leu Lys Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  30
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  30

Phe Met Lys Arg Arg His Ile Val His Lys His Thr Leu His Arg Ile 
1               5                   10                  15      


Leu Gln Asp Arg Glu 
            20      


<210>  31
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  31

Phe Met Lys Arg Arg His Ile Val His Lys His Thr Leu Arg Arg Arg 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  32
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  32

Phe Met Lys Arg Gln His Ile Val His Lys His Thr Leu His Arg Ile 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  33
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  33

Phe Met His Arg Arg His Leu Val Arg Arg Arg Thr Leu Arg His Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  34
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  34

Phe Met His Arg Lys Ile Val His Lys Lys Arg Thr Leu Arg His Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  35
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  35

Phe Met His Arg Arg His Leu Val His Arg Arg Thr Lys Arg His Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  36
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  36

Phe Met Arg Arg Arg His Ile Val Arg Lys Lys Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Asp Arg Asp 
            20      


<210>  37
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  37

Phe Met Arg Arg Arg Arg Ile Val Arg Lys Lys Thr Leu Arg Arg Arg 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  38
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  38

Phe Met Arg Arg Gln His Ile Val Arg Gln Lys Thr Leu Arg Arg Gln 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  39
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  39

Phe Met Arg Arg Arg His Ile Val Arg Lys Arg Thr Leu Arg Lys Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  40
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  40

Phe Met Arg Arg Lys Val His Val Arg Lys Arg Thr Leu Arg Lys Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  41
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  41

Phe Met Arg Arg Gln His Leu Val Gln Lys Arg Thr Leu Arg Lys Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  42
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  42

Phe Met Arg Lys Arg His Ile Val Arg Lys Arg Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Asp Arg Glu 
            20      


<210>  43
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  43

Phe Met Arg Lys Arg Arg Ile Val Arg Arg Arg Thr Leu Lys Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  44
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  44

Phe Met Arg Lys Arg His Ile Val Lys Lys Arg Thr Lys His Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Asp 
            20      


<210>  45
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  45

Phe Met Arg His Arg His Ile Val Arg Lys Arg Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  46
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  46

Phe Met Arg His Arg His Ile Val Arg Lys Arg Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  47
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  47

Phe Met Arg His Arg Val Ile Val His His Arg Thr Leu Arg Arg Lys 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  48
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  48

Phe Met Arg Arg Arg His Ile Val Arg Thr His Thr Leu Arg Lys Lys 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  49
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  49

Phe Met Arg Arg Arg Gln Ile Val Arg Gln His Thr Leu Arg Lys Lys 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  50
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  50

Phe Met Arg Arg Arg His Ile Leu Leu Thr His Thr Leu Arg Lys Lys 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  51
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  51

Phe Met Arg Arg Arg His Ile Val Arg Lys Lys Thr Leu Arg His Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  52
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  52

Phe Met Arg Arg Arg Lys Ile Val Arg Lys Lys Thr Leu Arg His Leu 
1               5                   10                  15      


Leu Gln Asp Arg Glu 
            20      


<210>  53
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  53

Phe Met Arg Arg Arg His Leu Val Leu Lys Lys Thr Leu Arg His Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  54
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  54

Phe Met Arg His Arg His Ile Val Arg Lys Arg Thr Leu Arg Lys Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  55
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  55

Phe Met Arg His Arg His Ile Val Arg Lys Arg Arg Arg Arg Lys Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  56
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  56

Phe Met Arg His Arg His Arg Val Arg Lys Arg Thr Arg Arg Lys Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  57
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  57

Phe Met Arg Lys Arg His Ile Val Arg Lys Arg Thr Leu Arg His Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  58
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  58

Phe Met Arg Lys Arg His Ile Val Arg Lys Arg Thr Leu Arg His Leu 
1               5                   10                  15      


Leu Gln Glu Arg Asp 
            20      


<210>  59
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  59

Phe Met Arg Lys Arg His Ile Val Arg Lys Arg Lys Leu Arg His Leu 
1               5                   10                  15      


Leu Gln Asp Arg Asp 
            20      


<210>  60
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  60

Phe Met Arg His Arg His Ile Val Arg Lys Lys Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  61
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  61

Phe Met Arg His Arg Lys Leu Val Arg Lys Lys Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  62
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  62

Phe Met Arg His Arg His Ile Val Leu Leu Lys Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  63
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  63

Phe Met Arg Lys Arg His Ile Val Arg Lys His Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  64
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  64

Phe Met Arg Lys Arg His Ile Val Arg Lys His Gln Leu Gln Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  65
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  65

Phe Met Arg Lys His His Ile Val Arg Lys His Thr Leu Arg Arg Leu 
1               5                   10                  15      


Gln Gln Glu Arg Glu 
            20      


<210>  66
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  66

Phe Arg Met His Lys Ile Arg Val Arg Thr Lys Leu Arg Leu Arg Leu 
1               5                   10                  15      


Arg Gln Glu Arg Glu 
            20      


<210>  67
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  67

Phe Arg Met His Arg Ile Arg Val Lys Thr Lys Leu Arg Leu Arg Leu 
1               5                   10                  15      


Arg Gln Asp Arg Glu 
            20      


<210>  68
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  68

Phe Arg Met His Arg Ile Arg Val Arg Thr Lys Leu Lys Leu Arg Leu 
1               5                   10                  15      


Arg Gln Glu Arg Glu 
            20      


<210>  69
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  69

Phe Arg Met His Arg Ile Arg Val Arg Thr Lys Leu Arg Leu Arg Leu 
1               5                   10                  15      


Lys Gln Glu Arg Glu 
            20      


<210>  70
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  70

Phe Arg Met His Arg Ile Gln Val Arg Thr Lys Leu Arg Gln Arg Leu 
1               5                   10                  15      


Arg Gln Asp Arg Glu 
            20      


<210>  71
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  71

Phe Met Arg Gln Arg His Ile Val Arg Gln Arg Thr Leu Arg Gln Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  72
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  72

Phe Met Arg Gln Arg His Ile Val Lys Gln Arg Thr Leu Arg Gln Leu 
1               5                   10                  15      


Leu Gln Asp Arg Glu 
            20      


<210>  73
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  73

Phe Met Arg Gln Arg His Ile Val Arg Gln Arg Thr Leu Arg Gln Leu 
1               5                   10                  15      


Leu Gln Glu 
            


<210>  74
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  74

Phe Met Arg Gln Arg His Ile Val Arg Gln Arg Thr Leu Arg Gln Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  75
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  75

Phe Met Arg Gln Arg His Ile Val Arg Gln Arg Thr Leu Lys Gln Leu 
1               5                   10                  15      


Leu Gln Asp Arg 
            20  


<210>  76
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  76

Phe Met Arg Gln Arg His Ile Val Arg Gln Arg Leu Leu Arg Gln Leu 
1               5                   10                  15      


His Gln Glu Arg Glu 
            20      


<210>  77
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  77

Phe Met Arg Gln Arg His Ile Val Leu Gln Arg Thr Leu Arg Gln Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  78
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  78

Phe Met Arg Gln Arg His Leu Leu Lys Gln Arg Thr Leu Arg Gln Leu 
1               5                   10                  15      


Leu Gln Glu 
            


<210>  79
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  79

Phe Met Arg Gln Arg His Leu Leu Lys Gln Gln Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu 
            


<210>  80
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  80

Val Arg Lys Arg Thr Leu Arg Arg Leu Leu Gln Glu Arg Glu 
1               5                   10                  


<210>  81
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  81

Arg Lys Arg Thr Leu Arg Arg Leu Leu Gln Glu Arg Glu 
1               5                   10              


<210>  82
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  82

Lys Arg Thr Leu Arg Arg Leu Leu Gln Glu Arg Glu 
1               5                   10          


<210>  83
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  83

Arg Thr Leu Arg Arg Leu Leu Gln Glu Arg Glu 
1               5                   10      


<210>  84
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  84

Arg Lys Arg Thr Leu Arg Arg Gln Leu Gln Glu Arg Glu 
1               5                   10              


<210>  85
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  85

Lys Arg Thr Arg Arg Arg Arg Leu Gln Glu Arg Glu 
1               5                   10          


<210>  86
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  86

Val Arg Lys Arg Val Leu Arg Arg Lys Lys Gln Glu Arg Glu 
1               5                   10                  


<210>  87
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  87

Val Arg Thr Lys Leu Arg Leu Arg Leu Arg Gln Glu Arg Glu 
1               5                   10                  


<210>  88
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  88

Arg Thr Lys Leu Arg Leu Arg Leu Arg Gln Glu Arg Glu 
1               5                   10              


<210>  89
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  89

Thr Lys Leu Arg Leu Arg Leu Arg Gln Glu Arg Glu 
1               5                   10          


<210>  90
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  90

Lys Leu Arg Leu Arg Leu Arg Gln Glu Arg Glu 
1               5                   10      


<210>  91
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  91

Val Arg Thr Lys Leu Arg Leu Arg Leu Arg Gln Glu 
1               5                   10          


<210>  92
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  92

Arg Thr Lys Leu Arg Leu Arg Leu Arg Gln Glu Arg 
1               5                   10          


<210>  93
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  93

Thr Lys Leu Arg Leu Arg Leu Arg Gln Glu 
1               5                   10  


<210>  94
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  94

Lys Leu Arg Leu Arg Leu Arg Gln Glu Arg 
1               5                   10  


<210>  95
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  95

Val Arg Thr Lys Leu Arg Gln Arg Leu Arg Gln Glu 
1               5                   10          


<210>  96
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  96

Arg Thr Lys Leu Arg Leu Arg Leu Leu Gln Glu Arg 
1               5                   10          


<210>  97
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  97

Gln Lys Leu Arg Leu Arg Leu Arg Gln Glu 
1               5                   10  


<210>  98
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence

<400>  98

Lys Leu Arg Lys Arg Leu Lys Gln Glu Arg 
1               5                   10  


<210>  99
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence


<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  R is 
       (R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-methyldec-9-eno
       ic acid

<220>
<221>  MOD_RES
<222>  (15)..(15)
<223>  S is 
       (S)-2-{[(99H-fluoren-9-yl)methoxy]carbonylamino}-2-methyl-hept-6-
       enoic acid

<400>  99

Phe Met Arg Arg Arg His Ile Arg Arg Lys Arg Thr Leu Arg Ser Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  100
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence


<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  R is 
       (R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-methyldec-9-eno
       ic acid

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  S is 
       (S)-2-{[(99H-fluoren-9-yl)methoxy]carbonylamino}-2-methyl-hept-6-
       enoic acid

<400>  100

Phe Met Arg Arg Arg His Ile Val Arg Lys Arg Thr Leu Arg Arg Ser 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  101
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  R is 
       (R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-methyldec-9-eno
       ic acid

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  S is 
       (S)-2-{[(99H-fluoren-9-yl)methoxy]carbonylamino}-2-methyl-hept-6-
       enoic acid

<400>  101

Arg Met Arg Arg Arg His Ile Ser Arg Lys Arg Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  102
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  R is 
       (R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-methyldec-9-eno
       ic acid

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  S is 
       (S)-2-{[(99H-fluoren-9-yl)methoxy]carbonylamino}-2-methyl-hept-6-
       enoic acid

<400>  102

Phe Arg Arg Arg Arg His Ile Val Ser Lys Arg Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  103
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence


<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  R is 
       (R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-methyldec-9-eno
       ic acid

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  S is 
       (S)-2-{[(99H-fluoren-9-yl)methoxy]carbonylamino}-2-methyl-hept-6-
       enoic acid

<400>  103

Phe Met Arg Arg Arg His Ile Val Arg Lys Arg Arg Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Ser Arg Glu 
            20      


<210>  104
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence


<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  R is 
       (R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-methyldec-9-eno
       ic acid

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  S is 
       (S)-2-{[(99H-fluoren-9-yl)methoxy]carbonylamino}-2-methyl-hept-6-
       enoic acid

<400>  104

Phe Met Arg Arg Arg His Ile Val Arg Ser Arg Thr Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  105
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence


<220>
<221>  MOD_RES
<222>  (5)..(5)
<223>  R is 
       (R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-methyldec-9-eno
       ic acid

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  S is 
       (S)-2-{[(99H-fluoren-9-yl)methoxy]carbonylamino}-2-methyl-hept-6-
       enoic acid

<400>  105

Phe Met Arg Arg Arg His Ile Val Arg Lys Arg Ser Leu Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  106
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence


<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  R is 
       (R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-methyldec-9-eno
       ic acid

<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  S is 
       (S)-2-{[(99H-fluoren-9-yl)methoxy]carbonylamino}-2-methyl-hept-6-
       enoic acid

<400>  106

Phe Met Arg Arg Arg Arg Ile Val Arg Lys Arg Thr Ser Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  107
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence


<220>
<221>  MOD_RES
<222>  (7)..(7)
<223>  R is 
       (R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-methyldec-9-eno
       ic acid

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  S is 
       (S)-2-{[(99H-fluoren-9-yl)methoxy]carbonylamino}-2-methyl-hept-6-
       enoic acid

<400>  107

Phe Met Arg Arg Arg His Arg Val Arg Lys Arg Thr Leu Ser Arg Leu 
1               5                   10                  15      


Leu Gln Glu Arg Glu 
            20      


<210>  108
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence


<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  R is 
       (R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-methyldec-9-eno
       ic acid

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  S is 
       (S)-2-{[(99H-fluoren-9-yl)methoxy]carbonylamino}-2-methyl-hept-6-
       enoic acid

<400>  108

Phe Met Arg Arg Arg His Ile Val Arg Arg Arg Thr Leu Arg Arg Leu 
1               5                   10                  15      


Ser Gln Glu Arg Glu 
            20      


<210>  109
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide sequence related to EGFR juxtamembrane 
       sequence


<220>
<221>  MOD_RES
<222>  (13)..(13)
<223>  R is 
       (R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-2-methyldec-9-eno
       ic acid

<220>
<221>  MOD_RES
<222>  (20)..(20)
<223>  S is 
       (S)-2-{[(99H-fluoren-9-yl)methoxy]carbonylamino}-2-methyl-hept-6-
       enoic acid

<400>  109

Phe Met Arg Arg Arg His Ile Val Arg Lys Arg Thr Arg Arg Arg Leu 
1               5                   10                  15      


Leu Gln Glu Ser Glu 
            20      


